The Immunohistochemistry Antibody Company

Home
Products
- All Antibodies
- IHC-plus Antibodies
Services
- Immunohistochemistry Studies
- Tissue Cross-Reactivity Screening
Distributors
Resources
- About our Tissue Bank
- Customer Support
- How to Buy
- IHC-plus Protocol
- LSBio Media
- Publications
- Antibody Reports
Company
- About LifeSpan
- Press Releases
- Holiday Schedule
- Contact Us

View Cart

General Cancer Screen 8 Tissue Microarray - LS-SCA8

This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.

Technical Help email

Request an IHC Study by email

PDF Spec Sheet - click here

Catalog ID:	LS-SCA8
Product Name:	General Cancer Screen 8
Description:	Multiple types of cancer with stage/grade and clinical data, and a normal specimen for each of 6 tissue types: Bladder, Breast, Kidney, Lung, Ovary, Uterus
Format:	FFPE
Category:	Human Multi-Tumor and Normal
QA/QC:	H&E reviewed
Storage:	Short term RT; Long term 4ºC
Clinical History:	Yes
Tissue Marker:	No
Stage/Grade:	Yes
Core Diameter:	1.5 mm
Core Thickness:	5-6 µm
Cores:	65
Slides Per Set:	1

LS-SCA8 Tissue Microarray Map

Slide Number 1

LABEL

	1	2	3	4	5	6	7	8	9	10	11
A	Pla		Ova	Ova	Ova	Ova	Ova	Ova	Ova	Ova	Ova
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst
D	Kid	Kid	Kid	Kid	Kid	Kid	Kid	Kid	Kid	Kid	Kid
E	Ute	Ute	Ute	Ute	Ute	Ute	Ute	Ute	Ute	Ute	Ute
F	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng

Diagnosis Type Legend

Benign non-neoplastic

Diseased

Inflammatory

Malignant

Metastatic

Tumor

Unknown

Element Tissue Legend

Bladder (Bla); Breast (Bst); Kidney (Kid); Lung (Lng); Ovary (Ova); Placenta (Pla); Uterus (Ute);

LS-SCA8 Element Details

Slide	Position	Species	Gender	Age	Tissue	Diagnosis	Diagnosis Type	TNM Tumor Classification	Tumor Differentiation	Tumor History	Tumor Size
1	A1	Human	F	29 y	Placenta (Pla)	Normal	Benign non-neoplastic
1	A3	Human	F	40 y	Ovary (Ova)	Adenocarcinoma, Mucinous	Malignant	T3N2M1	Poorly	5 Months	7x5x5 cm
1	A4	Human	F	60 y	Ovary (Ova)	Adenocarcinoma	Malignant	T3N1M1	Poorly	1 Month	5x5x4 cm
1	A5	Human	F	50 y	Ovary (Ova)	Adenocarcinoma	Malignant	T3N0M0	Moderately	1 Month	5x5x4.5 cm
1	A6	Human	F	63 y	Ovary (Ova)	Cystadenocarcinoma, Serous	Malignant	T3N1M0	Moderately	1 Month	6x5x5 cm
1	A7	Human	F	55 y	Ovary (Ova)	Clear cell adenocarcinoma	Malignant	T3N0M0	Poorly	3 Months	Diameter 13 cm
1	A8	Human	F	39 y	Ovary (Ova)	Matched adjacent normal	Benign non-neoplastic
1	A9	Human	F	39 y	Ovary (Ova)	Cystadenoma, Serous and papillary	Tumor		Poorly	2 Months	15x14x9 cm
1	A10	Human	F	51 y	Ovary (Ova)	Matched adjacent normal	Benign non-neoplastic
1	A11	Human	F	51 y	Ovary (Ova)	Thecoma	Tumor		Moderately
1	B1	Human	M	66 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2N0M0	Moderately	1 Month	4x3x3 cm
1	B2	Human	M	35 y	Bladder (Bla)	Transitional cell carcinoma	Malignant		Moderately	6 Years
1	B3	Human	M	61 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2N0M0	Poorly	15 Days	4x3.5x1.5 cm
1	B4	Human	M	77 y	Bladder (Bla)	Transitional cell carcinoma, Papillary	Malignant	T2N0M0	Well	2 Months	3x3x1.5 cm
1	B5	Human	M	75 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T3N0M0	Poorly	2 Years	6x5x2.5 cm
1	B6	Human	M	69 y	Bladder (Bla)	Transitional cell carcinoma, Papillary	Malignant	T3N0M0	Moderately	2 Months	8x8x1.5 cm
1	B7	Human	M	69 y	Bladder (Bla)	Transitional cell carcinoma, Papillary	Malignant	T2N0M0	Moderately	2 Years	3x3x2 cm
1	B8	Human	F	58 y	Bladder (Bla)	Matched adjacent normal	Benign non-neoplastic
1	B9	Human	F	58 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2N0M0	Moderately	3 Months	4x4x2.5 cm
1	B10	Human	M	20 y	Bladder (Bla)	Matched adjacent normal	Benign non-neoplastic
1	B11	Human	M	20 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2N0M0	Well	1 Month	3x3x1.5 cm
1	C1	Human	F	48 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	T2N0M0	Moderately	1 Year	Diameter 4 cm
1	C2	Human	F	44 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant		Well	4 Months	6x4x4 cm
1	C3	Human	F	82 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant		Moderately	4 Years	5x6 cm
1	C4	Human	F	41 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	T2N1M0	Moderately	2 Months	1x1x0.8 cm
1	C5	Human	F	78 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	T2N1M0	Moderately	1 Year	3x2 cm
1	C6	Human	F	26 y	Breast (Bst)	Fibroadenoma	Tumor	T2N0M0		2 Months	1.8x1.5x0.7 cm
1	C7	Human	F	58 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	T3N3M0	Moderately	2 Months	6x5x4 cm
1	C8	Human	F	56 y	Breast (Bst)	Matched adjacent normal	Benign non-neoplastic
1	C9	Human	F	56 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	T3N0M0	Moderately	1 Year	5x2x3 cm
1	C10	Human	F	36 y	Breast (Bst)	Matched adjacent normal	Benign non-neoplastic
1	C11	Human	F	36 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	T2N0M0	Well	2 Months	2x2 cm
1	D1	Human	M	50 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T2N0M0	Well	40 Days	3.5x3.5x3.2 cm
1	D2	Human	M	70 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T3N0M0	Poorly	7 Days	5.5x5 cm
1	D3	Human	M	64 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T2N0M0	Moderately	20 Days	4x3x3 cm
1	D4	Human	M	48 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T2N0M0	Moderately	30 Days	3x3x2.5 cm
1	D5	Human	M	50 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T2N0M0	Moderately-Poorly	20 Days	4x3x3 cm
1	D6	Human	F	50 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T3N0M0	Moderately	20 Days	6.5x5x5 cm
1	D7	Human	M	70 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T3N0M0	Moderately	15 Days	6x5x5 cm
1	D8	Human	M	60 y	Kidney (Kid)	Matched adjacent normal	Benign non-neoplastic
1	D9	Human	M	60 y	Kidney (Kid)	Transitional cell carcinoma	Malignant	T3N0M0	Moderately	1 Month	6x4x2.5 cm
1	D10	Human	M	33 y	Kidney (Kid)	Matched adjacent normal	Benign non-neoplastic
1	D11	Human	M	33 y	Kidney (Kid)	Renal cell carcinoma	Malignant	T2N0M0	Moderately	2 Months	2.5x2x2 cm
1	E1	Human	F	70 y	Uterus (Ute)	Endometrial papillary adenocarcinoma	Malignant	T2N0M0	Moderately	20 Days	3x2x1 cm
1	E2	Human	F	59 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T3N0M0	Moderately	2 Years	10x8x1.5 cm
1	E3	Human	F	61 y	Uterus (Ute)	Adenocarcinoma	Malignant	T1N2M0	Well	2 Months	Diameter 0.3 cm
1	E4	Human	F	25 y	Uterus (Ute)	Squamous cell carcinoma	Malignant	T3N0M0	Poorly	4 Months	5x2.5 cm
1	E5	Human	F	36 y	Uterus (Ute)	Adenomyoma	Tumor			7 Years	Diameter 7.5 cm
1	E6	Human	F	42 y	Uterus (Ute)	Adenoma	Tumor			1 Year	Diameter 4 cm
1	E7	Human	F	66 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T2N0M0	Well	3 Months	3x0.4x0.2 cm
1	E8	Human	F	52 y	Uterus (Ute)	Matched adjacent normal	Benign non-neoplastic
1	E9	Human	F	52 y	Uterus (Ute)	Leiomyoma	Tumor			3 Years	5x5x4 cm
1	E10	Human	F	50 y	Uterus (Ute)	Matched adjacent normal	Benign non-neoplastic
1	E11	Human	F	50 y	Uterus (Ute)	Leiomyoma	Tumor			6 Months	3x2x2 cm
1	F1	Human	M	58 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T3N2M0	Moderately	3 Months	5x4x4 cm
1	F2	Human	M	46 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T3N2M0	Moderately	45 Days	6x5x5 cm
1	F3	Human	M	63 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N3M0	Moderately	40 Days	3x3x2 cm
1	F4	Human	M	62 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T3N1M0	Moderately-Poorly	60 Days	5x4x4 cm
1	F5	Human	F	60 y	Lung (Lng)	Adenocarcinoma	Malignant		Poorly	24 Days	4x3.5x3.2 cm
1	F6	Human	M	60 y	Lung (Lng)	Squamous cell carcinoma	Malignant		Moderately	42 Days	3.7x3x3 cm
1	F7	Human	F	62 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	Poorly	20 Days	3x2.5x2.2 cm
1	F8	Human	F	50 y	Lung (Lng)	Matched adjacent normal	Benign non-neoplastic
1	F9	Human	F	50 y	Lung (Lng)	Adenocarcinoma	Malignant		Moderately-Poorly	1 Month	3x3x2.5 cm
1	F10	Human	M	63 y	Lung (Lng)	Matched adjacent normal	Benign non-neoplastic
1	F11	Human	M	63 y	Lung (Lng)	Bronchioloalveolar carcinoma	Malignant		Moderately	15 Days	7x5x5 cm

PLEASE NOTE

For RESEARCH USE ONLY. Not intended for human diagnostic or therapeutic purposes.

Not for resale without prior written consent from LifeSpan BioSciences, Inc.